Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Loss of HSulf-1 expression enhances autocrine signaling mediated by amphiregulin in breast cancer.

Narita K, Chien J, Mullany SA, Staub J, Qian X, Lingle WL, Shridhar V.

J Biol Chem. 2007 May 11;282(19):14413-20. Epub 2007 Mar 15.

2.

Amphiregulin as a novel target for breast cancer therapy.

Willmarth NE, Ethier SP.

J Mammary Gland Biol Neoplasia. 2008 Jun;13(2):171-9. doi: 10.1007/s10911-008-9081-9. Epub 2008 Apr 25. Review.

PMID:
18437539
3.

The role of amphiregulin in breast cancer.

Salomon DS, Normanno N, Ciardiello F, Brandt R, Shoyab M, Todaro GJ.

Breast Cancer Res Treat. 1995;33(2):103-14. Review.

PMID:
7749138
4.
5.

Amphiregulin: a new growth factor in hepatocarcinogenesis.

Berasain C, Castillo J, Perugorría MJ, Prieto J, Avila MA.

Cancer Lett. 2007 Aug 28;254(1):30-41. Epub 2007 Feb 26. Review.

PMID:
17321672
6.

Cripto monoclonal antibodies.

Hu XF, Xing PX.

Drug News Perspect. 2005 Jun;18(5):293-303. Review.

PMID:
16193101
7.

Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts.

Ferretti C, Bruni L, Dangles-Marie V, Pecking AP, Bellet D.

Hum Reprod Update. 2007 Mar-Apr;13(2):121-41. Epub 2006 Oct 26. Review.

8.

Targeting the heparin-binding epidermal growth factor-like growth factor in ovarian cancer therapy.

Tsujioka H, Yotsumoto F, Hikita S, Ueda T, Kuroki M, Miyamoto S.

Curr Opin Obstet Gynecol. 2011 Feb;23(1):24-30. doi: 10.1097/GCO.0b013e3283409c91. Review.

PMID:
20966750
9.

Autocrine, paracrine and juxtacrine signaling by EGFR ligands.

Singh AB, Harris RC.

Cell Signal. 2005 Oct;17(10):1183-93. Review.

PMID:
15982853
10.
11.

[Remodeling of basement membrane in association with cancer invasion].

Nakano S, Tsuruta J, Iyama K.

Rinsho Byori. 2000 May;48(5):451-7. Review. Japanese.

PMID:
10892294
12.

[Proteoglycans and breast cancer].

Delehedde M, Deudon E, Boilly B, Hondermarck H.

Pathol Biol (Paris). 1997 Apr;45(4):305-11. Review. French.

PMID:
9296079
13.

Regulatory mechanisms of the HB-EGF autocrine loop in inflammation, homeostasis, development and cancer.

Miyata K, Yotsumoto F, Nam SO, Kuroki M, Miyamoto S.

Anticancer Res. 2012 Jun;32(6):2347-52. Review.

PMID:
22641673
14.
15.

Glycan gene expression signatures in normal and malignant breast tissue; possible role in diagnosis and progression.

Potapenko IO, Haakensen VD, Lüders T, Helland A, Bukholm I, Sørlie T, Kristensen VN, Lingjaerde OC, Børresen-Dale AL.

Mol Oncol. 2010 Apr;4(2):98-118. doi: 10.1016/j.molonc.2009.12.001. Epub 2009 Dec 11. Review.

16.

Fatty acids and breast cancer cell proliferation.

Hardy RW, Wickramasinghe NS, Ke SC, Wells A.

Adv Exp Med Biol. 1997;422:57-69. Review.

PMID:
9361815
17.

Novel function of ovarian growth factors: combined studies by DNA microarray, biochemical and physiological approaches.

Ben-Ami I, Freimann S, Armon L, Dantes A, Ron-El R, Amsterdam A.

Mol Hum Reprod. 2006 Jul;12(7):413-9. Epub 2006 May 19. Review.

18.

Prolactin-induced protein in breast cancer.

Naderi A.

Adv Exp Med Biol. 2015;846:189-200. doi: 10.1007/978-3-319-12114-7_8. Review.

PMID:
25472539
19.

Stem cell fate decisions: the role of heparan sulfate in the control of autocrine and paracrine signals.

Grünert M, Nurcombe V, Cool SM.

Curr Stem Cell Res Ther. 2008 Jan;3(1):1-8. Review.

PMID:
18220917
20.

Quantitative aspects of autocrine regulation in tumors.

Bajzer Z, Vuk-Pavlović S.

Crit Rev Oncog. 1990;2(1):53-73. Review.

PMID:
1965422
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk